Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management

A Aslan, C Aslan, NM Zolbanin, R Jafari - Pneumonia, 2021 - Springer
COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …

Cardiovascular implications of the COVID-19 pandemic: a global perspective

M Boukhris, A Hillani, F Moroni, MS Annabi… - Canadian Journal of …, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …

Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry

RP Barbaro, G MacLaren, PS Boonstra, A Combes… - The Lancet, 2021 - thelancet.com
Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19
has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased …

Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization

J Badulak, MV Antonini, CM Stead… - Asaio …, 2021 - journals.lww.com
Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study

M Schmidt, D Hajage, G Lebreton, A Monsel… - The Lancet …, 2020 - thelancet.com
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

RP Barbaro, G MacLaren, PS Boonstra, TJ Iwashyna… - The Lancet, 2020 - thelancet.com
Background Multiple major health organisations recommend the use of extracorporeal
membrane oxygenation (ECMO) support for COVID-19-related acute hypoxaemic …

COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism

L Wenzhong, L Hualan - 2020 - chemrxiv.org
The novel coronavirus pneumonia is a contagious acute respiratory disease caused by the
SARS-COV-2 coronavirus. The pathogenic mechanism of the novel coronavirus is unknown …

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19

S Shaefi, SK Brenner, S Gupta, BP O'Gara… - Intensive care …, 2021 - Springer
Purpose Limited data are available on venovenous extracorporeal membrane oxygenation
(ECMO) in patients with severe hypoxemic respiratory failure from coronavirus disease 2019 …

ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida

E Oliveira, A Parikh, A Lopez-Ruiz, M Carrilo… - PloS one, 2021 - journals.plos.org
Background Observational studies have consistently described poor clinical outcomes and
increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who …

Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study

M Urner, AG Barnett, GL Bassi, D Brodie, HJ Dalton… - bmj, 2022 - bmj.com
Objective To estimate the effect of extracorporeal membrane oxygenation (ECMO)
compared with conventional mechanical ventilation on outcomes of patients with covid-19 …